Reports
Reports
Sale
The global therapeutic contact lens market size was valued at USD 3.86 billion in 2023, driven by the development of non-viral delivery systems across the globe. The market size is anticipated to grow at a CAGR of 8.15% during the forecast period of 2024-2032 to achieve a value of USD 7.82 billion by 2032.
Therapeutic contact lenses are used to manage eye conditions such as ocular surface diseases and several corneal diseases. These lenses are used in therapeutic management of corneal and ocular diseases. The therapeutic lenses help in management of eye conditions by creating a protective barrier between the cornea and external environment. It also provides pain relief, heals corneal wounds, and hydrate the corneal epithelium. Therapeutic lenses are used to manage a large variety of corneal conditions, including corneal erosions, corneal epithelial defects, and postsurgical conditions, such as post–laser vision correction.
The rise in initiatives by the key players to generate the contact lenses from eco-friendly materials is leading to increase in demand for therapeutic contact lenses. The effectiveness of the therapeutic contact lenses is a major factor contributing to the therapeutic contact lens market growth. Due to the involvement of advanced technologies and requirement of contact lenses for a variety of conditions, these lenses might potentially be able to monitor eye pressure, look for glaucoma (a disease that damages the optic nerve), and even produce images of the retinal vasculature for the early detection of hypertension, stroke and diabetes.
Market Breakup By Material
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by Region
The increasing number of users of contact lenses is increasing rapidly, leading to an increase in the demand for therapeutic contact lens across the globe. The increasing efforts by the governments to spread awareness about value of vision care has been contributing to the therapeutic contact lens market expansion.
Additionally, the increase in geriatric population, and the escalation in cornea surgeries, and developing infrastructure of healthcare across the globe has also been propelling the growth of the market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Material |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Therapeutic Contact Lens Market Overview
3.1 Global Therapeutic Contact Lens Market Historical Value (2017-2023)
3.2 Global Therapeutic Contact Lens Market Forecast Value (2024-2032)
4 Global Therapeutic Contact Lens Market Landscape
4.1 Global Therapeutic Contact Lens Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Therapeutic Contact Lens Product Landscape
4.2.1 Analysis by Material
4.2.2 Analysis by Application
5 Global Therapeutic Contact Lens Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Therapeutic Contact Lens Market Segmentation
6.1 Global Therapeutic Contact Lens Market by Material
6.1.1 Market Overview
6.1.2 Balafilacon
6.1.3 Lotrafilacon
6.1.4 Methafilacon
6.1.5 Senofilacon
6.1.6 Others
6.2 Global Therapeutic Contact Lens Market by Application
6.2.1 Market Overview
6.2.2 Drug Delivery
6.2.3 Corneal Surgery/Disorder
6.2.4 Pain Relief
6.2.5 Sealing and Protection
6.2.6 Others
6.3 Global Therapeutic Contact Lens Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Online Stores
6.3.4 Optical Retail Store
6.3.5 Others
6.4 Global Therapeutic Contact Lens Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Therapeutic Contact Lens Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Therapeutic Contact Lens Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Therapeutic Contact Lens Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Therapeutic Contact Lens Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Therapeutic Contact Lens Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Bausch & Lomb Pvt Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Advanced Vision Technologies
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 CooperVision
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Hoya Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 SEED Co., Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Bausch Health Companies, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Alcon Vision LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Johnson & Johnson Services, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Carl Zeiss AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 X-Cel Specialty Contacts
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 SynergEyes
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Therapeutic Contact Lens Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 3.86 billion in 2023, driven by the rising number of people with eye disorders.
The market is anticipated to grow at a CAGR of 8.15% during the forecast period of 2024-2032 to reach a value of USD 7.82 billion by 2032.
The growth of the market is driven by the rising healthcare sector, growing expenditure on healthcare sector by the government, rising key players, in the market as well as the increasing prevalence of eye diseases.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The types of material in the market include balafilacon, lotrafilacon, methafilacon, and senofilacon, others.
Therapeutic contact lens find wide applications in drug delivery, corneal surgery/disorder, pain relief, sealing and protection, among others.
The different channels of distribution of therapeutic contact lens include hospitals and clinics, online stores, and optical retail store, among others.
The escalating adoption of eco-friendly materials to develop the therapeutic contact lens is major trend in the market.
Key players involved in the market are Bausch & Lomb Pvt Ltd., Advanced Vision Technologies, CooperVision, Hoya Corporation, SEED Co., Ltd, Bausch Health Companies, Inc., Alcon Vision LLC, Johnson & Johnson Services, Inc., Carl Zeiss AG, X-Cel Specialty Contacts, and SynergEyes.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.